Dacryocystitis & Nasolacrimal Duct Obstruction

Overview

Nasolacrimal duct obstruction (NLDO) is blockage of tear outflow anywhere along the lacrimal drainage system, most often at the nasolacrimal duct itself, causing chronic epiphora (tearing) and predisposing the stagnant tear column to secondary infection. Dacryocystitis is infection/inflammation of the lacrimal sac, almost always occurring as a direct consequence of underlying NLDO, and can present acutely (painful, erythematous swelling) or chronically (recurrent mucoid discharge and low-grade inflammation).

Epidemiology & Risk Factors

NLDO can be congenital (common in infants, from incomplete canalization of the nasolacrimal duct, typically at the valve of Hasner, and usually resolving spontaneously or with simple probing) or acquired in adults, where it is more often idiopathic/involutional, though anatomic factors are clinically important: a deviated nasal septum and systemic conditions such as diabetes mellitus have both been identified as significant risk factors for treatment failure in adults undergoing surgical correction, reflecting their role in either anatomic obstruction or impaired healing/immune response.² Chronic dacryocystitis is a common cause of epiphora and can progress to lacrimal abscess if untreated.²

Pathophysiology

Obstruction of tear outflow, most commonly at the nasolacrimal duct, causes tears to stagnate within the lacrimal sac, creating an environment conducive to bacterial overgrowth and secondary infection (dacryocystitis). Cicatricial change within the duct — from prior inflammation, infection, or other structural narrowing — is a particularly important factor associated with reduced success of minimally invasive recanalization approaches, since scar tissue is less amenable to simple mechanical widening or stenting compared with membranous or mucoid obstruction.¹ Rarely, a mass lesion (benign or malignant) within the lacrimal sac or duct can itself cause obstruction and secondary dacryocystitis-like presentation, a critical masquerade to consider, particularly in atypical or treatment-resistant cases.³

Clinical Presentation

Chronic NLDO presents with persistent epiphora, often with mucoid or mucopurulent discharge expressible from the punctum on pressure over the lacrimal sac. Acute dacryocystitis presents with painful, erythematous swelling centered over the medial canthal region/lacrimal sac, sometimes with fluctuance if an abscess has formed, and can be accompanied by fever or preseptal cellulitis in more severe cases. A minority of lacrimal drainage apparatus lymphoma cases were found to be detected incidentally at the time of elective dacryocystorhinostomy surgery performed for presumed simple NLDO, underscoring that atypical presentations (or unremarkable findings that don't fully explain the clinical picture) warrant a high index of suspicion for an underlying mass lesion.³

Exam Findings

• Regurgitation of mucoid or purulent material from the punctum on pressure over the lacrimal sac (a classic diagnostic sign)
• Epiphora with a normal-appearing punctum and lid position (helping distinguish NLDO-related tearing from tearing due to eyelid malposition)
• Erythema, swelling, and tenderness over the medial canthal/lacrimal sac region in acute dacryocystitis
• A palpable mass in the medial canthus, which — while often simply a distended, obstructed lacrimal sac — should prompt consideration of an underlying neoplasm, especially if firm, fixed, or associated with atypical features
• On dacryoendoscopy, direct visualization of the site and character of obstruction (membranous, cicatricial, dacryolith, or diffuse), which can inform treatment approach and prognosis¹

Differential Diagnosis

• Simple congenital NLDO in an infant (typically resolves spontaneously or with simple probing, distinct from adult-onset acquired obstruction)
• Canalicular obstruction or punctal stenosis (a more proximal site of obstruction, distinguished by the pattern of irrigation and probing findings)
• Ocular adnexal lymphoma or other neoplasm of the lacrimal drainage apparatus — an important, potentially life-threatening masquerade, particularly when a mass, atypical imaging findings, or an unusual clinical course is present³
• Preseptal or orbital cellulitis from another source, distinguished by the absence of the classic lacrimal sac-centered findings and lack of associated epiphora history

Management

Diagnosis combines clinical examination (punctal regurgitation on sac pressure, assessment of lid position and punctal anatomy), lacrimal irrigation to confirm the level and completeness of obstruction, and, increasingly, dacryoendoscopy to directly visualize the character and location of obstruction within the duct.¹ Imaging (CT or dacryocystography) is reserved for atypical presentations, suspected mass lesions, or complex/recurrent cases.

Dacryocystorhinostomy (DCR) — creating a direct communication between the lacrimal sac and the nasal cavity, bypassing the obstructed nasolacrimal duct — is the definitive treatment for chronic NLDO and recurrent dacryocystitis, performed via either an external (through a skin incision) or endoscopic (endonasal) approach. Endoscopic DCR offers outcomes comparable to external DCR when performed with appropriate technique and adequate follow-up, avoiding an external scar.² In a tertiary center cohort undergoing primary endonasal DCR, patency on lacrimal sac syringing and stomal patency on endoscopy were achieved in 78.3% of patients at six months, with immediate complications generally mild (nasal bleeding, lid edema) and delayed complications including granulation tissue, synechiae, and stomal closure in a minority of cases; diabetes mellitus and deviated nasal septum were both significantly associated with surgical failure, with the combination of risk factors appearing to compound failure risk beyond either alone.²

For complete NLDO, a comparison of dacryoendoscopy-aided silicone tube intubation (a less invasive recanalization approach) against endoscopic DCR found numerically similar though not statistically significantly different success rates at both 3 and 6 months (84.6% vs. 91.2% at 3 months; 81.2% vs. 87.5% at 6 months, respectively), with cicatricial change identified as the key factor associated with reduced success following the less invasive intubation approach — supporting silicone tube intubation as a reasonable option in appropriately selected patients, particularly those preferring a less invasive initial approach, while recognizing DCR as the more robust option, especially when cicatricial obstruction is suspected.¹

Complications

• Lacrimal abscess formation from untreated or inadequately treated acute dacryocystitis
• Preseptal or, rarely, orbital cellulitis as a spreading complication of acute dacryocystitis
• Surgical failure (recurrent obstruction or persistent epiphora) after DCR, associated with risk factors including diabetes mellitus, deviated nasal septum, and cicatricial duct changes¹²
• Granulation tissue, synechiae, or stomal closure as delayed postoperative complications of endoscopic DCR²
• Missed lacrimal drainage apparatus neoplasm in a case treated as routine chronic dacryocystitis without adequate suspicion or tissue sampling³

Clinical Pearls

• Punctal regurgitation of mucoid/purulent material on pressure over the lacrimal sac is a classic, simple bedside sign supporting an NLDO/dacryocystitis diagnosis
• Diabetes mellitus and deviated nasal septum are both significant, and potentially synergistic, risk factors for DCR failure — proactive risk stratification and optimization matter²
• Cicatricial change within the duct is the key predictor of reduced success with less invasive recanalization (silicone tube intubation) approaches, favoring DCR when cicatricial disease is suspected¹
• Endoscopic DCR achieves outcomes comparable to external DCR while avoiding a visible scar, when performed with appropriate technique and follow-up²
• A lacrimal sac mass, atypical presentation, or disease incidentally found at DCR surgery should always raise suspicion for an underlying neoplasm such as lymphoma³

Common Pitfalls

• Assuming all chronic epiphora with a medial canthal mass represents simple obstructed dacryocystitis without considering an underlying neoplasm
• Proceeding with a less invasive recanalization approach in a patient with known or suspected cicatricial obstruction, where DCR is more likely to succeed
• Overlooking diabetes mellitus or anatomic risk factors (deviated septum) when counseling patients on expected surgical success rates
• Delaying DCR referral in recurrent dacryocystitis, risking repeated infections and abscess formation
• Failing to consider imaging or biopsy in atypical, treatment-resistant, or unusually presenting cases of presumed dacryocystitis